Company intelligence / Profile preview

Hebei Bio-High Technology Development

Shijiazhuang, Hebei, Chinabhsw.com.cn ↗

Ownership: Private
Development stage: Other

Overview

Bio-High is a modern biological high-tech enterprise with integrated R&D, manufacturing and sales of life science products. The company has original technology and a large number of achievements and products used in cellular research and diagnostics. It has contributed to the development of multi-targeting drugs and vaccines[1][2]. The company was involved in the rapid development and donation of COVID-19 antibody detection test papers during the pandemic[2].

Modalities: VaccineSmall moleculeBiologic
Industry: Biotech

Drug pipeline

6 assets

tumor-pulsed dendritic cells

5 more assets in the full pipeline.

Request access →

Partnerships

Hebei Overseas Chinese Chamber of Commerce (for COVID test paper donation)

Beyond the preview

Go deeper on Hebei Bio-High Technology Development.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hebei Bio-High Technology Development.

Explore the full profile